Robert S. Lowe - Concepedia

Author

Robert S. Lowe

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

R Lowe, R S Lowe, R. LOWE, R. Lowe, R. S. Lowe, R.S. Lowe, Robert Lowe, Robert S Lowe, Robert S. Lowe, Robert S. Lowe

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy Louisville Metabolic and Atherosclerosis Research Center The University of Texas Southwestern Medical Center Horticultural Research Institute

About

Robert S. Lowe is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, microbiology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	28	1.4K
2	Engineering	7	7	249
3	Public Health	4	4	89
4	Health Sciences	2	2	50
5	Natural Sciences	2	2	182

Robert S. Lowe

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus Paul M. Keller, Andrew J. Davison, Robert S. Lowe, Virology Virus StructureMolecular VirologyNatural SciencesVaricella-zoster VirusPathogenesis	1986	136
Human Papillomavirus Type 11 (HPV‐11) Neutralizing Antibodies in the Serum and Genital Mucosal Secretions of African Green Monkeys Immunized with HPV‐11 Virus‐like Particles Expressed in Yeast Robert S. Lowe, Darron R. Brown, Janine T. Bryan, The Journal of Infectious Diseases Veterinary VaccineHpv‐11 Virus‐like ParticlesViral PathogenesisImmunologyPathology	1997	130
Purification of Virus-like Particles of Recombinant Human Papillomavirus Type 11 Major Capsid Protein L1 from Saccharomyces cerevisiae James C. Cook, Joseph G. Joyce, Hugh A. George, Protein Expression and Purification Virus StructureViral ReplicationSaccharomyces CerevisiaeHuman Papillomavirus VaccinesPathogenesis	1999	105
Varicella-zoster virus as a live vector for the expression of foreign genes. Robert S. Lowe, Paul M. Keller, B J Keech, Proceedings of the National Academy of Sciences Synthetic VirologyImmunologyPathologyEpstein-barr VirusVirus Gene	1987	91
Correlation between Mouse Potency and In Vitro Relative Potency for Human Papillomavirus Type 16 Virus-Like Particles and Gardasil® Vaccine Samples Mary Shank-Retzlaff, F. Wang, Timothy Morley, Human Vaccines VaccinologyVaccinationVaccine DevelopmentAllergyHuman Papillomavirus Vaccines	2005	90
Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease††Conflicts of interest: Dr. Conard served as a consultant and advisor for Merck & Company and Merck/Schering-Plough. Dr. Bays received research grants from Amylin, San Diego, California, Amgen, Thousand Oaks, California, J&J, Langhorne, Pennsylvania, Aegerion, Bridgewater, New Jersey, Abbott, Chicago, Illinois, Arena Pharmaceuticals, San Diego, California, GlaxoSmithKline (Glaxo), London, UK, Hoffmann LaRoche, Nutley, New Jersey, Merck, Whitehouse Station, New Jersey, MSP, Kenilworth, New Jersey, Metabolex, San Jose, California, Schering-Plough, Kenilworth, New Jersey, Orexigen, San Diego, California, Reliant, Liberty Corner, New Jersey, Sciele, Atlanta, Georgia, Takeda, Osaka, Japan, TAP, Lake Forest, Illinois, and Vivus, Mountain View, California; received speakers' honoraria from Abbott, Daiichi Sankyo, Tokyo, Japan, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; received honoraria from Abbott, AstraZeneca, London, UK (Wilmington, Delaware, US Headquarters), Daiichi Sankyo, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; and served as a consultant and advisor for Abbott, GlaxoSmithKline, Metabolex, San Jose, California, Reliant, Takeda, AstraZeneca, and Essentialis, Carlsbad, California. Dr. Leiter received grants and speakers' honoraria from and served as a consultant and advisor for AstraZeneca, Merck & Company, Merck/Schering-Plough, and Pfizer, New York, New York. Mr. Bird, Mr. Rubino, and Drs. Lowe, Tomassini, and Tershakovec are employees of Merck & Company and may own stock and/or hold stock options in the company. Scott Conard, Harold Bays, Lawrence A. Leiter, The American Journal of Cardiology	2008	81
Studies on the initiation of bacterial soft rot in potato tubers M. C. M. Pérombelon, Robert S. Lowe Potato Research Bacterial Soft RotFood SpoilagePlant PathologyMicrobiologyPotato Tubers	1975	74
Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study) Harold Bays, Michael H. Davidson, Rachid Massaad, The American Journal of Cardiology ThrombosisLipid DisorderCardiovascular DiseaseMedicineHyperlipidemia	2011	74
Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin Susan G. Lakoski, Fang Xu, Gloria Lena Vega, The Journal of Clinical Endocrinology & Metabolism	2009	73
Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia D. Meeike Kusters, Maria Caceres, Mauricio Coll, The Journal of Pediatrics Pediatric HematologyEzetimibe MonotherapyPediatricsNonfamilial HypercholesterolemiaHeterozygous Familial	2015	69

Page 1